Novartis Investigative Site
Orchard Park, New York 14127
We've found
1 trials
at this facility
Ankylosing Spondylitis Clinical Trial
Updated: 12/31/1969
Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
